Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
American Journal of Hematology|September 23, 1997
Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphomaR D Legare, J G Gribben, M Maragh, et al.Leukemia|February 3, 1998
CBFA2, frequently rearranged in leukemia, is not responsible for a familial leukemia syndromeR D Legare, D Lu, M Gallagher, et al.Blood|June 17, 1998
Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution studyS Mach-Pascual, R D Legare, D Lu, et al.Blood|June 15, 1996
Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2C Y Ho, B Otterud, R D Legare, et al.Breast Cancer Research and Treatment|June 4, 2021
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) studyM L Lopresti, J J Bian, B J Sakr, et al.Nature Genetics|October 3, 1999
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW J Song, M G Sullivan, R D Legare, et al.Pageof 1